(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -3.62%184.4B | -5.73%118.81B | 0.15%65.37B | 3.11%254.4B | 4.01%191.32B | 7.84%126.03B | 0.03%65.27B | 20.31%246.72B | 26.59%183.95B | 22.68%116.87B |
Operating income | -3.62%184.4B | -5.73%118.81B | 0.15%65.37B | 3.11%254.4B | 4.01%191.32B | 7.84%126.03B | 0.03%65.27B | 20.31%246.72B | 26.59%183.95B | 22.68%116.87B |
Operating expenses | 7.12%-154.85B | 6.53%-54.86B | 7.01%-166.72B | 6.64%-58.69B | -33.93%-179.29B | |||||
Gross profit | 20.10%29.55B | 59.71%10.51B | 428.01%24.6B | 175.80%6.58B | -59.28%4.66B | |||||
Selling expenses | 6.51%-180.19M | ---- | 4.15%-47.6M | ---- | -15.28%-192.74M | ---- | 1.99%-49.66M | ---- | -8.29%-167.19M | ---- |
Administrative expenses | -11.34%-4.6B | ---- | -5.76%-1.38B | ---- | -10.68%-4.13B | ---- | -4.88%-1.3B | ---- | 0.58%-3.73B | ---- |
Research and development expenses | -31.62%-1.15B | -18.52%-607.84M | -5.35%-205.86M | ---- | -30.26%-875.84M | ---512.85M | -154.16%-195.4M | ---- | -123.35%-672.38M | ---- |
Profit from asset sales | -109.60%-8.31M | ---- | -91.86%54.82K | ---- | -19.40%86.57M | ---- | -91.16%673.78K | ---- | -40.36%107.41M | ---- |
Employee expense | ---- | -17.07%-8.68B | ---- | -10.00%-17.76B | ---- | -10.16%-7.42B | ---- | -0.19%-16.15B | ---- | 2.22%-6.73B |
Depreciation and amortization | ---- | -1.00%-12.74B | ---- | -4.56%-25.49B | ---- | -5.32%-12.61B | ---- | -9.45%-24.38B | ---- | -7.90%-11.97B |
Impairment and provision | -653.76%-1.06B | 131.38%19.49M | -794.95%-8.63M | -167.34%-129.01M | -97.89%-140.23M | 4.19%-62.11M | -15.70%1.24M | 53.43%-48.26M | -755.93%-70.86M | ---64.82M |
-Other impairment is provision | -653.76%-1.06B | 131.38%19.49M | -794.95%-8.63M | -167.34%-129.01M | -97.89%-140.23M | 4.19%-62.11M | -15.70%1.24M | 53.43%-48.26M | -755.93%-70.86M | ---64.82M |
Special items of operating profit | -61.50%1.75B | 12.13%-81.4B | 29.15%686.39M | 7.85%-190.82B | 102.59%4.55B | 5.27%-92.65B | -40.78%531.46M | -20.36%-207.08B | 13.43%2.25B | -45.90%-97.8B |
Operating profit | 0.72%22.88B | 20.28%14.49B | 74.79%9.06B | 881.58%18.56B | 1,604.71%22.72B | 3,582.97%12.05B | 230.55%5.18B | 66.81%-2.37B | -83.47%1.33B | -103.72%-345.98M |
Financing income | ---- | 41.97%298.56M | ---- | 49.41%506.88M | ---- | 31.74%210.3M | ---- | 17.68%339.26M | ---- | 18.22%159.64M |
Financing cost | 11.53%-5.96B | 11.16%-4.04B | 3.74%-2.05B | 10.28%-8.94B | 7.30%-6.73B | 10.90%-4.55B | 16.13%-2.13B | -13.23%-9.96B | -16.92%-7.27B | -19.89%-5.11B |
Share of profits of associates | ---- | 9.94%858.12M | ---- | -18.04%854.16M | ---- | 15.89%780.55M | ---- | 22.88%1.04B | ---- | -27.33%673.54M |
Special items of earning before tax | -672.66%-464.95M | -312.67%-233.09M | -117.26%-12.73M | 954.63%1.49B | -68.93%81.19M | -167.10%-56.48M | 52.58%73.79M | 397.24%141.59M | 529.89%261.33M | 228.97%84.18M |
Earning before tax | 2.45%16.46B | 34.86%11.38B | 123.64%7B | 215.38%12.48B | 383.32%16.07B | 286.01%8.44B | 440.18%3.13B | 27.25%-10.81B | -416.77%-5.67B | -175.04%-4.53B |
Tax | -18.79%-3.1B | -19.66%-1.95B | -74.52%-1.16B | -2,236.93%-3.71B | -1,509.80%-2.61B | -552.14%-1.63B | -246.41%-665.28M | -108.22%-158.66M | 126.75%185.33M | 134.03%359.64M |
After-tax profit from continuing operations | -0.73%13.36B | 38.50%9.43B | 136.91%5.84B | 179.92%8.77B | 345.26%13.45B | 263.08%6.81B | 321.60%2.46B | 15.16%-10.97B | -599.89%-5.49B | -183.73%-4.18B |
Earning after tax | -0.73%13.36B | 38.50%9.43B | 136.91%5.84B | 179.92%8.77B | 345.26%13.45B | 263.08%6.81B | 321.60%2.46B | 15.16%-10.97B | -599.89%-5.49B | -183.73%-4.18B |
Minority profit | 230.60%2.94B | 418.18%1.66B | 480.79%1.24B | 113.98%411.95M | 157.69%890.29M | 133.45%319.48M | 237.35%213.7M | -15.28%-2.95B | -3,160.58%-1.54B | -219.41%-955.05M |
Profit attributable to shareholders | -17.12%10.41B | 19.81%7.77B | 104.25%4.6B | 204.13%8.36B | 418.69%12.56B | 301.53%6.49B | 335.30%2.25B | 22.66%-8.03B | -476.56%-3.94B | -176.91%-3.22B |
Basic earnings per share | -19.70%0.53 | 25.00%0.4 | 150.00%0.25 | 153.85%0.35 | 288.57%0.66 | 218.52%0.32 | 211.11%0.1 | 18.75%-0.65 | -775.00%-0.35 | -235.00%-0.27 |
Diluted earnings per share | -19.70%0.53 | 25.00%0.4 | 150.00%0.25 | 153.85%0.35 | 288.57%0.66 | 218.52%0.32 | 211.11%0.1 | 18.75%-0.65 | -775.00%-0.35 | -235.00%-0.27 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming, Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming, Ernst & Young (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data